Northwest Biotherapeutics (NWBO) Intangibles (2020 - 2026)

Northwest Biotherapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $52.0 million for Q1 2026.

• In Q1 2026, Intangibles rose 3928.48% year-over-year to $52.0 million; the TTM figure through Mar 2026 stood at $52.0 million (up 3928.48% YoY), while the FY2025 annual figure was $53.2 million, up 4016.72% from the prior year.
• Intangibles for Q1 2026 stood at $52.0 million, down from $53.2 million in the prior quarter.
• The five-year high for Intangibles was $53.2 million in Q4 2025, with the low at $1.3 million in Q1 2022.
• The 5-year median for Intangibles is $1.3 million (2022), against an average of $7.3 million.
• The sharpest annual moves came in 2022 and 2025: Intangibles changed 0.0% in 2022, then surged 4016.72% in 2025.
• Northwest Biotherapeutics' Intangibles stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then soared by 4016.72% to $53.2 million in 2025, then declined by 2.14% to $52.0 million in 2026.
• Business Quant data shows NWBO's Intangibles at $52.0 million in Q1 2026, $53.2 million in Q4 2025, and $1.3 million in Q3 2025.